Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes ( LIVE )—a multicentre, double‐blind, randomised, placebo‐controlled trial-Reference-Cited by-同舟云学术

Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes ( LIVE )—a multicentre, double‐blind, randomised, placebo‐controlled trial

Published:2016-10-28 Issue:1 Volume:19 Page:69-77
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Jorsal Anders¹²,Kistorp Caroline³⁴,Holmager Pernille³,Tougaard Rasmus Stilling¹²,Nielsen Roni¹²,Hänselmann Anja⁵,Nilsson Brian⁶,Møller Jacob Eifer⁵,Hjort Jakob²,Rasmussen Jon³⁴,Boesgaard Trine Welløv⁷,Schou Morten⁴⁸,Videbæk Lars⁵,Gustafsson Ida⁶,Flyvbjerg Allan²⁹¹⁰,Wiggers Henrik¹²,Tarnow Lise⁷⁹¹¹

Affiliation:

1. Department of Cardiology Aarhus University Hospital Aarhus Denmark

2. Department of Clinical Medicine, Faculty of Health Aarhus University Aarhus Denmark

3. Department of Endocrinology and Internal Medicine Herlev University Hospital Copenhagen Denmark

4. Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

5. Department of Cardiology Odense University Hospital Odense Denmark

6. Department of Cardiology Hvidovre University Hospital Copenhagen Denmark

7. Steno Diabetes Center Gentofte Denmark

8. Department of Cardiology Herlev and Gentofte University Hospital Copenhagen Denmark

9. Faculty of Health Aarhus University Aarhus Denmark

10. Department of Endocrinology and Internal Medicine Aarhus University Hospital Aarhus Denmark

11. Nordsjællands University Hospital Hillerød Denmark

Funder

Bayer

Daiichi-Sankyo

Novo Nordisk

Novartis

Pfizer

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.657

Reference31 articles.

1. Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT‐HF).Lancet1999;353:2001–2007.

3. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

4. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

5. The biology of incretin hormones

Cited by 384 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise and weight loss with a left ventricular assist device: A case report and review of the literature;Current Problems in Cardiology;2024-10

2. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

3. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life;Cardiac Failure Review;2024-09-11

4. Semaglutide and heart failure: Updated meta-analysis.;Current Problems in Cardiology;2024-09

5. Improving Health Status With SGLT2 Inhibitors Following Worsening Heart Failure;Journal of the American College of Cardiology;2024-09